RenovaCare Inc.

RenovaCare Inc. is a clinical-stage biotechnology company specializing in the development of autologous cellular therapies intended for medical and aesthetic applications. The company’s primary innovation is the CellMist System, a platform combining a cell isolation methodology with a specialized solution sprayer device. This system is designed to facilitate the regeneration of human skin and other tissues by delivering a patient’s own cells directly to areas requiring treatment. RenovaCare’s focus on autologous techniques—using the patient’s own cells—aims to advance therapies that improve outcomes in wound healing, skin repair, and regenerative medicine. Operating as a development-stage entity, RenovaCare supports ongoing research and commercialization efforts targeted at both medical and cosmetic markets. Established in 1983 and based in Scottsdale, the company occupies a niche at the intersection of biotechnology and medical device innovation, seeking to broaden the scope and efficacy of regenerative healthcare solutions.